Evaluation of adenosine 5'-diphosphate (ADP)- and collagen-induced platelet aggregation in canine leishmaniasis. 2004

A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
Dipartimento di Strutture, Funzioni e Tecnologie Biologiche, University of Napoli, Federico II, 80137 Napoli, Italy.

Leishmania-infected dogs, which represent an important reservoir of infection in many parts of the world, frequently suffer from haematological disorders, including thrombocytopenia. In this study, the ability of platelets from healthy (control) dogs (n = 11) and from dogs with naturally acquired clinical leishmaniasis (n = 24) to aggregate in the presence of two different agonists (adenosine 5'-diphosphate [ADP] and collagen) was assayed. Haematological parameters examined consisted of the platelet count, prothrombin time, activated partial thromboplastin time (aPTT), fibrinogen concentration and D-dimer concentration. In dogs with leishmaniasis, a significant decrease in ADP- and collagen-induced platelet aggregation was observed. Compared with platelets from the control dogs, those from leishmania-infected dogs showed a higher sensitivity to collagen, as demonstrated by a reduction in platelet aggregation of up to 20.4%, and a significant (P < 0.0001) difference for all the doses tested. With ADP the reduction was up to 10.4%, the difference reaching a significant level of P < 0.0001 only at the maximum dose used. The nature of this response, which was not accompanied by any clinical signs of bleeding other than an increase in aPTT, emphasizes the role of platelets in the parasite-host cell interaction.

UI MeSH Term Description Entries
D007896 Leishmaniasis A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). Leishmania Infection,Infection, Leishmania,Infections, Leishmania,Leishmania Infections,Leishmaniases
D008297 Male Males
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D010976 Platelet Count The number of PLATELETS per unit volume in a sample of venous BLOOD. Blood Platelet Count,Blood Platelet Number,Platelet Number,Blood Platelet Counts,Blood Platelet Numbers,Count, Blood Platelet,Count, Platelet,Counts, Blood Platelet,Counts, Platelet,Number, Blood Platelet,Number, Platelet,Numbers, Blood Platelet,Numbers, Platelet,Platelet Count, Blood,Platelet Counts,Platelet Counts, Blood,Platelet Number, Blood,Platelet Numbers,Platelet Numbers, Blood
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females

Related Publications

A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
November 1972, British journal of pharmacology,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
September 1987, Quaderni Sclavo di diagnostica clinica e di laboratorio,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
June 2002, Blood,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
December 1979, Thrombosis and haemostasis,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
June 1991, Transplantation proceedings,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
June 1980, Biochemical pharmacology,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
January 1974, Scandinavian journal of haematology,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
July 1998, Blood,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
August 2003, Journal of veterinary pharmacology and therapeutics,
A Pelagalli, and P Ciaramella, and P Lombardi, and M E Pero, and L Cortese, and M Corona, and G Oliva, and L Avallone
December 1967, Laboratory investigation; a journal of technical methods and pathology,
Copied contents to your clipboard!